Trends in Peptide and Protein Sciences <p style="text-align: justify;">The <em>Trends in Peptide and Protein Sciences</em> is a peer-reviewed, online-only (previously print-online), scientific journal owned by <strong>Protein Technology Research Center</strong>,<strong> Shahid Beheshti University of Medical Sciences</strong> and documents in all important aspects of the research in peptides and proteins focusing on analytics and impurities, bioinformatics, biopharmaceuticals and vaccines, biotechnology, chemical synthesis, conformational analysis, design and&nbsp; development of protein therapeutics, determination of structure, enzymology, folding and sequencing,&nbsp; formulation and stability, function, genetics,&nbsp; immunology, kinetics, modeling, molecular biology, pharmacokinetics and pharmacodynamics of therapeutic proteins and antibodies, pharmacology,&nbsp; protein engineering and development, protein-protein interaction, proteomics, purification/expression/production, simulation, thermodynamics and&nbsp; hydrodynamics and protein biomarkers. The aim of this Journal is to publish high quality original research articles, reviews, short communications and letters and to provide a medium for scientists and researchers to share their findings from the area of peptides and proteins. <span class="st">The </span><em><strong>Trends in Peptide and Protein Sciences</strong></em><span class="st"> is published in collaboration with </span><a title="Link of Iranian Association of Pharmaceutical Scientists Website" href="" target="_blank" rel="noopener"><strong>Iranian Association of Pharmaceutical Scientists</strong></a><span class="st">.</span></p> <p><span class="st">&nbsp;</span></p> <p>&nbsp;</p> Protein Technology Research Center, Shahid Beheshti University of Medical Sciences en-US Trends in Peptide and Protein Sciences 2538-2535 <p>Upon publication, author(s) agree that the journal of <em>Trends in Peptide and Protein Sciences</em> is the copyright owner of the material published. All works published in the TPPS are open access and are available to anyone on the web site of the journal without cost. The users are free to use the work, subject to proper attribution of authorship and ownership of the rights. Authors may use their material in presentations and subsequent publications they write or edit themselves, provided that the TPPS is referenced in writing and is acknowledged as the original publication.</p> <p><strong>Creative Common Attribution Non-Commercial 4.0 International License </strong><span class="cc-license-identifier"><strong>(CC BY-NC 4.0)</strong> </span></p> <p>This is an open access journals that articles distributed under the terms of <strong><a title="CC By NC-4.0" href="" target="_blank" rel="noopener">Creative Common Attribution Non-Commercial 4.0 International License</a></strong> which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work properly cited.</p> Identification of Proteins Participating in the Cisplatin Resistance Following Treatment with Cisplatin in A2780 and A2780CP Ovarian Cell Lines <p>Ovarian cancer is the most fatal gynecological cancer and the 8<sup>th</sup> most prevalent type of cancer in Iran. Chemotherapy regimen for the treatment of this type of cancer is mostly based on platinum agents and paclitaxel. The major problem during treatment with cisplatin is the appearance of acquired resistance in cancer cells in the first 6 months of therapy. Owing to inefficacy of second line regimens, it seems necessary to find out the molecular mechanisms of cisplatin resistance and find an efficient strategy against the resistant cancer cells. In this study, two ovarian cancer cell lines, A2780-sensitive and A2780CP (resistant to cisplatin) were evaluated. To acquire the protein expression profile, a culture of each line containing 1.5×10<sup>7 </sup>cells was divided into the two groups of control and treatment cells. The treatment group cells were treated with cisplatin at pre-determined IC<sub>50</sub> concentration for 6 hours. Then, the total proteins of 7×10<sup>6</sup> cells were extracted. The proteome of each group (20 μg) was used for subsequent separation of proteins by two-dimensional gel electrophoresis using 7 cm IPG strips. The results of protein pattern changes were analyzed by one-way ANOVA. At least 230 proteins were detected in each gel, from which, about 45 proteins were differentially expressed in each model of comparison. However, by considering the results of all models of analysis on the protein expression profile of two cell lines, three proteins were determined as the key players of resistance against cisplatin. </p> <p><strong>HIGHLIGHTS</strong></p> <ul> <li>The major problem during treatment with cisplatin is the appearance of acquired resistance in cancer cells.</li> <li>The cisplatin- resistant and sensitive ovarian cell lines of A2780 were evaluated in this study.</li> <li>Proteomics analysis was run using 2D gel electrophoresis after cisplatin treatment.</li> <li>Three proteins were determined as the key players of resistance against cisplatin in A2780 cell line.</li> </ul> Kamyar Keshavarz Farajkhah Maryam Tabarzad Farshad Hosseini Shirazi Mohammad Hassan Houshdar Tehrani Copyright (c) 2020 Trends in Peptide and Protein Sciences 2020-03-04 2020-03-04 5 1 6 10.22037/tpps.v5i0.28873 Effect of High Salinity on Mycosporine-Like Amino Acid Production in Desmodesmus sp. <p>Mycosporine like amino acids (MAAs) are UV absorbing compounds which are produced by a variety of organisms such as algae and cyanobacteria, in order to protect themselves from harmful UV irradiation. Thus, they can potentially be used as sunscreens in pharmaceutical and cosmetic industry. Many abiotic factors are studied which induce the production of MAAs in algae and cyanobacteria. In this investigation, we have cultivated the green microalga <em>Desmodesmus</em> sp. under salt stress and studied the effect of high salinity on MAAs biosynthesis. MAAs was extracted and partially purified using HPLC method. One compound with similar properties to MAAs was detected from the biomass extract, having a maximum absorption at 320 nm. Accordingly, this genus of microalgae can produce MAA-like compound under this condition, whereas it was not capable to synthesize MAA in normal condition. In fact, salinity is a stressor which can lead to the induction of MAAs synthesis in this microalga. Moreover, this investigation supports that the production of MAAs in microalgae helps the organism to survive in harsh environments, such as high salinity conditions.</p> <p><strong>HIGHLIGHTS</strong></p> <ul> <li>Mycosporine like amino acids (MAAs) can be considered as valuable sunscreens.</li> <li>High salinity condition can induce MAAs production.</li> <li><em>Desmodesmus </em>sp<em>. </em>in high salinity medium can produce MAA compound.</li> </ul> Rouzbeh Gharib Maryam Tabarzad Tahereh Hosseinabadi Copyright (c) 2020 Trends in Peptide and Protein Sciences 2020-03-04 2020-03-04 5 1 6 10.22037/tpps.v5i0.28876 Purification and Properties of Thermostable Fucoidanase Produced by Recently Isolated Terrestrial Aspergillus flavus FS018 <p>In this study fucoidanase produced by terrestrial Apsergillus flavus FS018 was purified and characterized. The pure fucoidanase enzyme was found to have an optimum activity of 20.8U/mL at 55 ºC and optimum activity of 17.2U/mL at pH 5.0. Furthermore, the fucoidanase retained 96% of its activity after 8 hours of incubation at 55 ºC. Metal ions such Mg2+ and Ca2+ ions were found to slightly enhance the activity of this enzyme while Na+, K+ had inhibitory effect on the activity. The enzyme was found to be active towards fucoidan consisting of α-1→4 and α-1→3 glycoside bonds in the main chains and also galactofucans group. Estimation of the kinetic parameters of the enzyme revealed that Km and Vmax to be 1.9 mM and 0.38 mg/min, respectively when fucoidan from Sargassum vulgare was used as substrate. SDS-PAGE analysis of the purified enzyme revealed that it’s a monomeric enzyme molecule with an estimated molecular weight of 70 kDa.</p> <p><strong>HIGHLIGHTS</strong></p> <ul> <li>Fucoidanase from Aspergillus flavus FS018 was purified and characterized.</li> <li>Molecular weight of the enzyme was estimated to be 70kDa.</li> <li>Enzyme was active towards fucoidan consisting of α-1→4 and α-1→3 glycoside bonds in the main chains and also galactofucans group.</li> </ul> Emmanuel O. Garuba Paul A. Adeleye Abiodun A. Onilude Copyright (c) 2020 Trends in Peptide and Protein Sciences 2020-07-29 2020-07-29 5 1 7 10.22037/tpps.v5i0.30913 N-Succinyl-L,L-Diaminopimelic Acid Desuccinylase (DapE) a Potential Biomarker of Mycobacterium Tuberculosis: Tag-Free Purification by Metal Affinity Chromatography <p>DapE is an enzyme which is highly essential in lysine biosynthetic pathway for the growth and survival of <em>Mycobacterium tuberculosis </em>(<em>Mtb</em>) and other bacterial species although absent in human host. However, the sequence identity of <em>Mtb</em>-DapE with other mycobacterium and bacterial species estimated between 93 to 75% and approximately 50%, respectively. DapE is a metallo-enzyme requires few of transition metals for activity and bacterial proliferation. The homology model based structural studies including published structures revealed an availability of zinc interacting conserved amino residues in <em>Mtb</em>-DapE. In this study, we purified full length recombinant <em>Mtb</em>-DapE as tag-free (<em>Mtb</em>-DapE<sub>TagFree</sub>) protein from inclusion bodies using zinc-NTA column. The single step purified protein observed with 96-98% purity and high yield. The indirect ELISA had 40% sensitivity using <em>Mtb</em>-DapE as an antigen against bovine tuberculosis (bTB) serum samples. IFA analysis with clear fluorescent spots of <em>Mtb</em> native DapE antigen in (3+) human TB positive sputum samples and recombinant <em>Mtb</em>-DapE positive control against <em>Mtb</em>-DapE polyclonal antibody are highly encouraging. The ELISA and IFA results incite for the consideration of <em>Mtb</em>-DapE in future development of quick and ideal TB detection assay along with other <em>mycobacterium</em> antigens. The future advanced detailed structural and functional studies using this highly purified and tag-free <em>Mtb</em>-DapE may provide discovery of antitubercular drug(s) and promising inhibitory molecules.</p> <p><strong>HIGHLIGHTS </strong></p> <ul> <li>Expression and purification of recombinant Mtb-DapE<sub>TagFree</sub>.</li> <li>On-column refolded protein with 98% purity from inclusion bodies purified by zinc-NTA column affinity chromatography.</li> <li>The purified protein observed no aggregation and degradation even after 8 months storage.</li> <li>ELISA and IFA results supports for development of detection assay for TB from tubercular samples.</li> </ul> <p><strong> <img src="/public/site/images/mtabarzad/-2-Graphical_abstract_modified_05082020-With_legend1.jpg"></strong></p> Chinmay Umbarkar Prashant Thakre Supriya Kashikar Niraj Ghanwate Vinod Agarkar Copyright (c) 2020 Trends in Peptide and Protein Sciences 2020-09-08 2020-09-08 5 1 9 10.22037/tpps.v5i0.31578